Latest News

News

Our new year’s resolutions

Resolve to improve your use of electronic health records to make your life easier in the coming year.

Conference Coverage

Semaglutide compares well with sitagliptin

NEW ORLEANS – Semaglutide, a GLP-1 agonist for type 2 diabetes that’s dosed weekly, was superior to daily sitagliptin in improving glycemic...

Pages